1190900-25-4Relevant articles and documents
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists
Du, Wu,Jewell, James P.,Lin, Linus S.,Colandrea, Vincent J.,Xiao, Jing C.,Lao, Julie,Shen, Chun-Pyn,Bateman, Thomas J.,Reddy, Vijay B.G.,Ha, Sookhee N.,Shah, Shrenik K.,Fong, Tung M.,Hale, Jeffrey J.,Hagmann, William K.
scheme or table, p. 5195 - 5199 (2010/03/24)
Obesity is a chronic medical condition that is affecting large population throughout the world. CB1 as a target for treatment of obesity has been under intensive studies. Taranabant was discovered and then developed by Merck as the 1st generation CB1R inv
